The effect of berberine and fenugreek seed co-supplementation on inflammatory factor, lipid and glycemic profile in patients with type 2 diabetes mellitus: a double-blind controlled randomized clinical trial

Table 2 Basic anthropometric indices of patients with type 2 diabetes

Characteristics	Intervention group (n = 25)	Placebo group (n = 25)	P-value^a
Weight (kg)
Baseline	71.51 (10.87)	75.06 (11.16)	0.2
End of trial	70.82 (11.52)	74.18 (9.72)	0.1
P-value^b	0.1	0.1
WC (cm)
Baseline	100.08 (9.77)	97.28 (13.89)	0.2
End of trial	99.32 (10.05)	96.32 (13.58)	0.3
P-value^b	0.03	0.02
HC (cm)
Baseline	103.32 (11.12)	103.4 (11.67)	0.9
End of trial	102.78 (11.16)	102.72 (11.61)	0.9
P-value^b	0.04	0.06
BMI (kg/m²)
Baseline	27.56 (4.07)	27.62 (3.31)	0.6
End of trial	27.15 (4.17)	27.17 (3.11)	0.6
P-value^b	0.06	0.03

BMI body mass index, HC hip circumference, PA physical activity, WC waist circumference, MET metabolic equivalent of task
^*Mean (SD)done
P-value^a P values denote significance of between-group difference (P < 0.05, independent samples t-test or U Mann Whitney)
P-value^b P values denote significance of within-group changes (P < 0.05, paired samples t-test or Wilcoxon)

ISSN: 1758-5996